Xencor, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:XNCR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 904.69 M879.42 M868.81 M875.5 M736.85 M Total liabilities 264.81 M259.07 M243.5 M239.91 M221.21 M Total equity 639.87 M620.35 M625.32 M635.59 M515.63 M Total liabilities & shareholders' equities 904.69 M879.42 M868.81 M875.5 M736.85 M Total debt 154.38 M145.02 M133.14 M119.75 M108.53 M Net debt 154.38 M145.02 M133.14 M119.75 M108.53 M

News

Xencor: Bullish On Their Increasingly In-House Pipeline (NASDAQ:XNCR)

Xencor, Inc. (XNCR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates

Corcept Therapeutics (CORT) Reports Q1 Loss, Misses Revenue Estimates

Xencor at Barclays Healthcare Conference: Pipeline Progress and Strategic Plans

Xencor, Inc. (XNCR) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Xencor at Leerink Global Healthcare: Strategic Development Insights

Royalty Rift: Alexion Cuts Off US Royalty Payments To Xencor - AstraZeneca (NYSE:AZN), Xencor (NASDAQ:XNCR)

Xencor faces royalty dispute with Alexion over Ultomiris sales

Xencor at TD Cowen Conference: Strategic Focus on Oncology and Autoimmune

Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates

Xencor Inc earnings beat by $0.51, revenue fell short of estimates